View in EDS PDF Full Text

AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.

Saved in:
Bibliographic Details
Title: AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Authors: Strecker MI; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Wlotzka K; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Strassheimer F; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Roller B; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Ludmirski G; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., König S; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Röder J; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Opitz C; Institute for Transfusion Medicine, German Red Cross Blood Donation Service North-East and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany., Alekseeva T; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Reul J; Paul-Ehrlich-Institut, Molecular Biotechnology and Gene Therapy, Langen, Germany., Sevenich L; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Tonn T; Institute for Transfusion Medicine, German Red Cross Blood Donation Service North-East and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany., Wels WS; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Steinbach JP; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Buchholz CJ; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Paul-Ehrlich-Institut, Molecular Biotechnology and Gene Therapy, Langen, Germany.; German Cancer Consortium (DKTK), partner site Heidelberg, Heidelberg, Germany., Burger MC; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.
Source: Oncoimmunology [Oncoimmunology] 2022 Oct 11; Vol. 11 (1), pp. 2127508. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36249274
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Strecker+MI%22">Strecker MI</searchLink>; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Wlotzka+K%22">Wlotzka K</searchLink>; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Strassheimer+F%22">Strassheimer F</searchLink>; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Roller+B%22">Roller B</searchLink>; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Ludmirski+G%22">Ludmirski G</searchLink>; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22König+S%22">König S</searchLink>; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Röder+J%22">Röder J</searchLink>; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Opitz+C%22">Opitz C</searchLink>; Institute for Transfusion Medicine, German Red Cross Blood Donation Service North-East and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Alekseeva+T%22">Alekseeva T</searchLink>; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Reul+J%22">Reul J</searchLink>; Paul-Ehrlich-Institut, Molecular Biotechnology and Gene Therapy, Langen, Germany.<br /><searchLink fieldCode="AU" term="%22Sevenich+L%22">Sevenich L</searchLink>; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Tonn+T%22">Tonn T</searchLink>; Institute for Transfusion Medicine, German Red Cross Blood Donation Service North-East and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Wels+WS%22">Wels WS</searchLink>; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Steinbach+JP%22">Steinbach JP</searchLink>; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Buchholz+CJ%22">Buchholz CJ</searchLink>; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Paul-Ehrlich-Institut, Molecular Biotechnology and Gene Therapy, Langen, Germany.; German Cancer Consortium (DKTK), partner site Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Burger+MC%22">Burger MC</searchLink>; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2022 Oct 11; Vol. 11 (1), pp. 2127508. <i>Date of Electronic Publication: </i>2022 Oct 11 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36249274
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2022.2127508
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2127508
    Titles:
      – TitleFull: AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Strecker MI
      – PersonEntity:
          Name:
            NameFull: Wlotzka K
      – PersonEntity:
          Name:
            NameFull: Strassheimer F
      – PersonEntity:
          Name:
            NameFull: Roller B
      – PersonEntity:
          Name:
            NameFull: Ludmirski G
      – PersonEntity:
          Name:
            NameFull: König S
      – PersonEntity:
          Name:
            NameFull: Röder J
      – PersonEntity:
          Name:
            NameFull: Opitz C
      – PersonEntity:
          Name:
            NameFull: Alekseeva T
      – PersonEntity:
          Name:
            NameFull: Reul J
      – PersonEntity:
          Name:
            NameFull: Sevenich L
      – PersonEntity:
          Name:
            NameFull: Tonn T
      – PersonEntity:
          Name:
            NameFull: Wels WS
      – PersonEntity:
          Name:
            NameFull: Steinbach JP
      – PersonEntity:
          Name:
            NameFull: Buchholz CJ
      – PersonEntity:
          Name:
            NameFull: Burger MC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 10
              Text: 2022 Oct 11
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2162-402X
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1